| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Financial Officer | EVP &Chief Financial Officer
1 company
Schorno Dean L is an EVP &Chief Financial Officer at RIGEL PHARMACEUTICALS INC. Recent SEC Form 4 filings include 2 buys and 5 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Financial Officer | Sell | 3,770 | $21.38 | $80,614.84 | -3.1% | -20.1% | +45.4% | |
| Feb 5, 2024 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Financial Officer | Sell | 12,628 | $1.14 | $14,337.67 | -1.5% | +4.3% | +78.3% | |
| Feb 2, 2023 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Financial Officer | Sell | 5,389 | $1.66 | $8,946.28 | -2.7% | -35.0% | -35.6% | |
| May 22, 2019 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Financial Officer | Buy | 50,000 | $2.13 | $106,544.11 | +107.0% | - | - |